October is shaping up to be an excellent month for Public discussions sponsored by the FDA. The latest to be announced is a SBIR symposium on pharmaceutical product quality to be held in College Park, MD on October 16-17. The agenda covers the agencies practices for facilities and approval inspections, post-approval quality and change management, emerging technologies (with a special emphasis on continuous manufacturing), and biologics, wrapping up the second day with discussions on forthcoming guidance on the “deemed to be a license” provision of the Biologic Price Competition and Innovation Act of 2009 (you can read more about that topic here. This is another event that may be attended virtually, and the sessions will be recorded and available on the conference web site within 24 hours after each session concludes.
Reach out to me if you want to know more or discuss your medical product development needs.
https://calendly.com/katrinarogers
Text Copyright © 2019 Katrina Rogers